Gert Ossenkoppele MD, PhD

Professor Gert Ossenkoppele is professor of Hematology at the VU University Medical Center in Amsterdam. He obtained his doctorate of medicine at that same University in 1977. The title of his PhD thesis (1990) was :”Differentiation induction in AML”. Gert Ossenkoppele has authored over 370 publications in peer-reviewed journals. His research interests is mainly translational and include the (stem cell)biology of AML/CML/MDS, immunotherapy and minimal residual disease (MRD) detection using flow cytometry to inform treatment of myeloid malignancies (AML, CML and MDS).

He is PI of national and international cliical trials in myeloid malignancies.He is a past board member of the Dutch Society of Hematology. He recently stepped back as chief editor of the Dutch Journal of Hematology. He is associate editor of J of Oncopathology and the European Journal of Haematology. He chairs the AML working party of HOVON( Dutch-Belgian Hematology Trial Group) and elected as secretary of the HOVON board. He is a lead participant of the AML Workpackage of the European LeukemiaNet(ELN) as well as a boardmember of ELN foundation.